132 related articles for article (PubMed ID: 3006911)
1. Loss of alleles at polymorphic loci on chromosome 2 in uveal melanoma.
Mukai S; Dryja TP
Cancer Genet Cytogenet; 1986 May; 22(1):45-53. PubMed ID: 3006911
[TBL] [Abstract][Full Text] [Related]
2. Deletion mapping of chromosome region 9p21-p22 surrounding the CDKN2 locus in melanoma.
Ohta M; Berd D; Shimizu M; Nagai H; Cotticelli M-G ; Mastrangelo M; Shields JA; Shields CL; Croce CM; Huebner K
Int J Cancer; 1996 Mar; 65(6):762-7. PubMed ID: 8631588
[TBL] [Abstract][Full Text] [Related]
3. Loss of chromosome 3 alleles and multiplication of chromosome 8 alleles in uveal melanoma.
Horsthemke B; Prescher G; Bornfeld N; Becher R
Genes Chromosomes Cancer; 1992 Apr; 4(3):217-21. PubMed ID: 1382562
[TBL] [Abstract][Full Text] [Related]
4. Loss of polymorphic restriction fragments in malignant melanoma: implications for tumor heterogeneity.
Dracopoli NC; Houghton AN; Old LJ
Proc Natl Acad Sci U S A; 1985 Mar; 82(5):1470-4. PubMed ID: 2983346
[TBL] [Abstract][Full Text] [Related]
5. Multiple locations on chromosome 3 are the targets of specific deletions in uveal melanoma.
Cross NA; Ganesh A; Parpia M; Murray AK; Rennie IG; Sisley K
Eye (Lond); 2006 Apr; 20(4):476-81. PubMed ID: 15920570
[TBL] [Abstract][Full Text] [Related]
6. Loss of heterozygosity on chromosomes 3, 9, 13, and 17, including the retinoblastoma locus, in uveal melanoma.
Scholes AG; Liloglou T; Maloney P; Hagan S; Nunn J; Hiscott P; Damato BE; Grierson I; Field JK
Invest Ophthalmol Vis Sci; 2001 Oct; 42(11):2472-7. PubMed ID: 11581185
[TBL] [Abstract][Full Text] [Related]
7. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma.
Aalto Y; Eriksson L; Seregard S; Larsson O; Knuutila S
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):313-7. PubMed ID: 11157859
[TBL] [Abstract][Full Text] [Related]
8. Loss of heterozygosity of 1p in uveal melanomas with monosomy 3.
Häusler T; Stang A; Anastassiou G; Jöckel KH; Mrzyk S; Horsthemke B; Lohmann DR; Zeschnigk M
Int J Cancer; 2005 Oct; 116(6):909-13. PubMed ID: 15849744
[TBL] [Abstract][Full Text] [Related]
9. Loss of heterozygosity of the thyroid hormone receptor B in posterior uveal melanoma.
Sisley K; Curtis D; Rennie IG; Rees RC
Melanoma Res; 1993 Dec; 3(6):457-61. PubMed ID: 7909244
[TBL] [Abstract][Full Text] [Related]
10. Loss of alleles from the distal short arm of chromosome 1 occurs late in melanoma tumor progression.
Dracopoli NC; Harnett P; Bale SJ; Stanger BZ; Tucker MA; Housman DE; Kefford RF
Proc Natl Acad Sci U S A; 1989 Jun; 86(12):4614-8. PubMed ID: 2734311
[TBL] [Abstract][Full Text] [Related]
11. Chromosome 10 allelic loss in malignant melanoma.
Isshiki K; Elder DE; Guerry D; Linnenbach AJ
Genes Chromosomes Cancer; 1993 Nov; 8(3):178-84. PubMed ID: 7509626
[TBL] [Abstract][Full Text] [Related]
12. A third Wilms' tumor locus on chromosome 16q.
Maw MA; Grundy PE; Millow LJ; Eccles MR; Dunn RS; Smith PJ; Feinberg AP; Law DJ; Paterson MC; Telzerow PE
Cancer Res; 1992 Jun; 52(11):3094-8. PubMed ID: 1317258
[TBL] [Abstract][Full Text] [Related]
13. Fine mapping of chromosome 3 in uveal melanoma: identification of a minimal region of deletion on chromosomal arm 3p25.1-p25.2.
Parrella P; Fazio VM; Gallo AP; Sidransky D; Merbs SL
Cancer Res; 2003 Dec; 63(23):8507-10. PubMed ID: 14679017
[TBL] [Abstract][Full Text] [Related]
14. Analysis of p16 (CDKN2/MTS-1/INK4A) alterations in primary sporadic uveal melanoma.
Merbs SL; Sidransky D
Invest Ophthalmol Vis Sci; 1999 Mar; 40(3):779-83. PubMed ID: 10067984
[TBL] [Abstract][Full Text] [Related]
15. Detection of c-myc amplification in uveal melanoma by fluorescent in situ hybridization.
Parrella P; Caballero OL; Sidransky D; Merbs SL
Invest Ophthalmol Vis Sci; 2001 Jul; 42(8):1679-84. PubMed ID: 11431428
[TBL] [Abstract][Full Text] [Related]
16. Loss of alleles at loci on human chromosome 11 during genesis of Wilms' tumour.
Koufos A; Hansen MF; Lampkin BC; Workman ML; Copeland NG; Jenkins NA; Cavenee WK
Nature; 1984 May 10-16; 309(5964):170-2. PubMed ID: 6325936
[TBL] [Abstract][Full Text] [Related]
17. Partial deletions of the long and short arm of chromosome 3 point to two tumor suppressor genes in uveal melanoma.
Tschentscher F; Prescher G; Horsman DE; White VA; Rieder H; Anastassiou G; Schilling H; Bornfeld N; Bartz-Schmidt KU; Horsthemke B; Lohmann DR; Zeschnigk M
Cancer Res; 2001 Apr; 61(8):3439-42. PubMed ID: 11309305
[TBL] [Abstract][Full Text] [Related]
18. Uveal melanocytomas: genetic comparison with uveal and dermal melanomas.
Fogt F; Selim AM; Xu GX; Prinz MK; Eagle RC; Budimlija ZM
Arch Ophthalmol; 2005 Mar; 123(3):377-80. PubMed ID: 15767481
[TBL] [Abstract][Full Text] [Related]
19. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma.
Edmunds SC; Kelsell DP; Hungerford JL; Cree IA
Invest Ophthalmol Vis Sci; 2002 Sep; 43(9):2845-51. PubMed ID: 12202501
[TBL] [Abstract][Full Text] [Related]
20. Clinical and cytogenetic analyses in uveal melanoma.
Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
